Colorectal Neoplasms: all 5,734 studies
Page 56 of 58. Open to participants first (1,481), then studies with results posted, then the rest; newest registration first within each.
- Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal CancerCompletedNCT00118261Phase 1
- S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal CancerWithdrawnNCT00118105Phase 2
- Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal CancerCompletedNCT00116506Phase 2
- A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal CancerTerminatedNCT00114946Phase 4
- Magnetic Resonance (MR) Colonography With Fecal TaggingCompletedNCT00114842Phase 4
- Preoperative Assessment of Colon TumorStatus unknownNCT00114829Phase 4
- Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal CancerCompletedNCT00113776Phase 2
- GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal CancerTerminatedNCT00110721Phase 2
- A Study to Evaluate Avastin in Combination With Chemotherapy in Patients With Metastatic Colorectal CancerCompletedNCT00109226Phase 2
- A Study to Evaluate Avastin in Combination With Standard Chemotherapy to Treat Colorectal CancerCompletedNCT00109070Phase 3
- Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver MetastasesCompletedNCT00107861Phase 1/2
- AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)CompletedNCT00107250Phase 1
- Neoadjuvant Colorectal Cancer With Unresectable Liver MetastasesTerminatedNCT00106054Phase 2
- Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal CancerCompletedNCT00104689Phase 2
- Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal CancerCompletedNCT00103298Phase 2
- Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal CancerCompletedNCT00102011Phase 3
- Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal CancerCompletedNCT00101894Phase 1
- MK0457 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Colorectal Cancer and Other Advanced Solid Tumors (0457-001)TerminatedNCT00099346Phase 1
- Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal CancerCompletedNCT00098982Phase 1
- A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer StudyCompletedNCT00096967Phase 3
- Folate-Depleted Diet Compared With Folate-Supplemented Diet in Preventing Colorectal Cancer in Patients at High Risk for Colorectal CancerCompletedNCT00096330Phase 1
- Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colorectal CancerTerminatedNCT00091286Early Phase 1
- Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the LiverCompletedNCT00089401Phase 2
- Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy ParticipantsCompletedNCT00087360Not applicable
- Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal CancerTerminatedNCT00087334Phase 1/2
- Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the RectumCompletedNCT00086931Phase 1/2
- Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the ColonCompletedNCT00085163Phase 3
- Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal CancerCompletedNCT00084721Phase 1
- Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver MetastasesCompletedNCT00083785Phase 2
- Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard TherapiesStatus unknownNCT00081536Phase 1/2
- OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal CancerCompletedNCT00081237Phase 1
- Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00080951Phase 2
- Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Line Treatment of Colorectal CancerCompletedNCT00079872Phase 2
- Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal CancerCompletedNCT00079066Phase 3
- Study of the GARFT Inhibitor AG2037 in Patients With Metastatic Colorectal Cancer Who Failed TreatmentCompletedNCT00078468Phase 2
- Assessment Of Safety And Efficacy Of SU11248 In Patients With Metastatic Colorectal Cancer Who Have Failed Selected Previous Treatments.CompletedNCT00077987Phase 2
- FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal CancerCompletedNCT00077337Phase 2
- Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal CancerCompletedNCT00077259Phase 2
- Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal CancerStatus unknownNCT00075595Phase 2
- Neoadjuvant Radiation Therapy and Capecitabine in Treating Patients With Stage III or Stage IV Colorectal AdenocarcinomaStatus unknownNCT00075556Phase 2
- A Study of ABT-751 in Patients With Colorectal CancerCompletedNCT00073138Phase 2
- Study Evaluating EKB-569 in Advanced Colorectal CancerCompletedNCT00072748Phase 2
- Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00072553Phase 2
- Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal CancerTerminatedNCT00072098Phase 1
- S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the RectumWithdrawnNCT00070434Phase 2
- Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal CancerCompletedNCT00070213Phase 3
- Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver MetastasesCompletedNCT00068068Phase 2
- Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard ChemotherapyCompletedNCT00066846Phase 2
- Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal CancerCompletedNCT00066274Phase 2
- Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.TerminatedNCT00065117Phase 2
- Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal CancerCompletedNCT00064181Phase 3
- Hepatic Arterial Infusion With Floxuridine and Systemic Irinotecan After Surgery in Treating Patients With Hepatic (Liver) Metastases From Colorectal CancerCompletedNCT00063960Phase 2
- Study Evaluating MAC-321 in Colorectal CancerCompletedNCT00063427Phase 2
- Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal CancerCompletedNCT00063141Phase 3
- Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal CancerCompletedNCT00062426Phase 3
- Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal CancerTerminatedNCT00062023Phase 2
- Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal CancerCompletedNCT00061815Phase 3
- Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal CancerCompletedNCT00059930Phase 1
- Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal CancerStatus unknownNCT00058474Phase 3
- A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid MalignanciesStatus unknownNCT00057395Phase 1/2
- Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.CompletedNCT00056459Phase 3
- Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal CancerCompletedNCT00056446Phase 3
- Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal CancerCompletedNCT00056030Phase 2
- Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal CancerCompletedNCT00055822Phase 1/2
- A Study of Cetuximab in Patients Who Have Stage IV Colorectal CancerCompletedNCT00055419Phase 2
- An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon CancerCompletedNCT00054912Phase 1
- Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal CancerCompletedNCT00052507Phase 2
- Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal CarcinomaCompletedNCT00051987Phase 2
- Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal CancerTerminatedNCT00051688Phase 2
- S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically RemovedCompletedNCT00049335Phase 2
- Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00049101Phase 1/2
- A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal CancerCompletedNCT00048139Phase 2
- A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal CancerCompletedNCT00048126Phase 2
- Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal CancerCompletedNCT00047762Phase 1
- Genetic Study of Young Patients With Colorectal CancerCompletedNCT00044967
- Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal CarcinomaCompletedNCT00044863Phase 2
- GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or OxaliplatinCompletedNCT00044343Phase 2
- A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Colorectal Cancer Resistant to Standard TherapiesStatus unknownNCT00043199Phase 2
- Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal NeoplasiaCompletedNCT00043043Phase 2
- Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal CancerTerminatedNCT00043004Phase 2
- Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the LiverCompletedNCT00041808Phase 1/2
- Safety Study of 90Y-hMN14 to Treat Colorectal Cancer Patients With Limited Residual Disease After SurgeryTerminatedNCT00041691Phase 1
- Safety Study of hMN14 to Treat Either Colorectal or Breast CancerCompletedNCT00041652Phase 1/2
- Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal CancerCompletedNCT00040820Not applicable
- Safety Study of 90Y-hMN14 to Treat Colorectal CancerCompletedNCT00040599Phase 1/2
- A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal CancerTerminatedNCT00040391Phase 2
- Massage Therapy for Cancer-Related FatigueCompletedNCT00039793Phase 2
- Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerCompletedNCT00039611Not applicable
- Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00039273Phase 2
- Combination Chemotherapy in Treating Patients With Colorectal CancerCompletedNCT00039208Phase 2
- For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With ChemotherapyTerminatedNCT00037180Phase 2
- Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal CancerTerminatedNCT00036517Phase 1/2
- Safety and Efficacy of Targeted Gene Transfer in Colorectal Cancer Metastatic to LiverWithdrawnNCT00035919Phase 1/2
- EPO906 Therapy in Patients With Advanced Colorectal CancerCompletedNCT00035087Phase 2
- A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic CancerCompletedNCT00034827Phase 2
- A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.CompletedNCT00034619Phase 2
- A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.CompletedNCT00034502Phase 1/2
- Acupuncture to Reduce Symptoms of Advanced Colorectal CancerCompletedNCT00034034Phase 1
- Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the LiverCompletedNCT00033748Phase 2
- Aspirin and/or Folic Acid in Preventing Recurrent Colorectal PolypsStatus unknownNCT00033319Not applicable